Too Old to Operate45m
Age Differences Seen in Efficacy of Type 2 Diabetes Treatments
Age differences are seen in the efficacy of treatments for type 2 diabetes, according to a study published online Feb. 3 in ...
Healio7h
SGLT2s, GLP-1s reduce risk for COPD exacerbations
Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD exacerbation in adults with the disease and type 2 diabetes, researchers ...
Healio11h
SLGT2s, GLP-1s reduce risk for COPD exacerbations
Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD exacerbation in adults with the disease and type 2 diabetes, researchers ...
Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’
Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...
NASM Launches New Understanding Weight Loss Medications Course
Based Review of GLP-1/GIP Agonists for Fitness and Wellness ProfessionalsGilbert, AZ, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The ...
emjreviews.com21h
High Discontinuation Rates of GLP-1 RAs Among Patients Without Type 2 Diabetes
Study finds that a significant proportion of adults prescribed GLP-1 RAs for weight management discontinue treatment within a ...
Daily21h
Elective Peri-Operative Management of Patients on GLP-1, GIP Agonists & SGLT-2 Inhibitors: Multidisciplinary Consensus Released
UK: A recent consensus statement from leading UK medical organizations-including the Association of Anaesthetists,the ...